Radiation Oncology/Therapy: Page 214

Dara touts oncology treatment product
By AuntMinnie.com staff writers
Oncology and oncology-support specialty pharmaceutical company Dara BioSciences said it has launched a new product for treating skin irritation and burns associated with radiation therapy.
June 5, 2012
State population predicts radiation therapy staffing
By AuntMinnie.com staff writers
State population is a significant predictor of radiation therapy staffing levels, according to a study from the American Society of Radiologic Technologists.
June 4, 2012
Oncology Services International names CEO
By AuntMinnie.com staff writers
Radiation oncology device service company Oncology Services International has named Richard J. Hall as its new president and CEO.
June 4, 2012
ASCO: Patient income affects trial enrollment
By AuntMinnie.com staff writers
The lower their income, the less likely patients are to participate in cancer clinical trials, according to a study presented at the American Society of Clinical Oncology (ASCO) annual meeting, currently under way in Chicago.
June 3, 2012
ASCO: Childhood radiation therapy boosts breast cancer risk
By Cynthia E. Keen
Women who had radiation therapy for childhood cancers have an elevated risk of breast cancer later in life, similar to that of women with BRCA mutations, according to a study presented on Monday at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
June 3, 2012
ASCO: Sirtex touts colorectal cancer study
By AuntMinnie.com staff writers
Sirtex Medical is promoting a study of the use of its microspheres for treating patients with unresectable colorectal cancer liver metastases. Results were presented on Monday at the American Society of Clinical Oncology (ASCO) annual meeting being held in Chicago.
June 3, 2012
Beta-carotene safe for prostate cancer patients
By AuntMinnie.com staff writers
The antioxidant supplement beta-carotene is safe to use during radiation therapy treatments for prostate cancer, according to a study published in the May issue of the International Journal of Radiation Oncology, Biology, Physics.
May 31, 2012
Chemo with RT improves survival for brain tumor patients
By Cynthia E. Keen
Patients with oligodendroglioma brain tumors with a specific chromosomal abnormality double their survival outcomes when they undergo a combined chemoradiotherapy treatment, according to long-term findings of a clinical trial that will be presented this week at the American Society of Clinical Oncology meeting.
May 30, 2012
Landauer inks deal with Gamma Basics
By AuntMinnie.com staff writers
Landauer Medical Physics, a segment of radiation monitoring firm Landauer, has announced a partnership with Gamma Basics.
May 30, 2012
Long-term outcomes reinforce RT for Hodgkin's lymphoma
By Cynthia E. Keen
Radiation therapy (RT) following chemotherapy carries the risk of future complications for children and young adults with Hodgkin's lymphoma, but results published online May 29 in the Journal of Clinical Oncology show that patients who received radiotherapy after chemo had a lower risk of cancer recurrence.
May 30, 2012
SBRT instead of IMRT could reduce cost of prostate treatment
By Cynthia E. Keen
When a patient with organ-confined prostate cancer needs radiation therapy, replacing intensity-modulated radiation therapy (IMRT) with stereotactic body radiation therapy (SBRT) may be more cost-effective, according to an article published in the May issue of the Journal of Oncology Practice.
May 30, 2012
Elekta to highlight Mosaiq upgrades at ASCO
By AuntMinnie.com staff writers
Radiation oncology firm Elekta plans to highlight upgrades to its Mosaiq oncology information system at the upcoming American Society of Clinical Oncology (ASCO) meeting in Chicago.
May 29, 2012
Previous Page
Page 214 of 464
Next Page